Literature DB >> 23940284

Congenital dyserythropoietic anemias: molecular insights and diagnostic approach.

Achille Iolascon1, Hermann Heimpel, Anders Wahlin, Hannah Tamary.   

Abstract

The congenital dyserythropoietic anemias (CDAs) are hereditary disorders characterized by distinct morphologic abnormalities of marrow erythroblasts. The unveiling of the genes mutated in the major CDA subgroups (I-CDAN1 and II-SEC23B) has now been completed with the recent identification of the CDA III gene (KIF23). KIF23 encodes mitotic kinesin-like protein 1, which plays a critical role in cytokinesis, whereas the cellular role of the proteins encoded by CDAN1 and SEC23B is still unknown. CDA variants with mutations in erythroid transcription factor genes (KLF1 and GATA-1) have been recently identified. Molecular diagnosis of CDA is now possible in most patients.

Entities:  

Mesh:

Year:  2013        PMID: 23940284      PMCID: PMC3785118          DOI: 10.1182/blood-2013-05-468223

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  47 in total

1.  Defective gene expression, S phase progression, and maturation during hematopoiesis in E2F1/E2F2 mutant mice.

Authors:  Feng X Li; Jing W Zhu; Christopher J Hogan; James DeGregori
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

2.  Mutations affecting the secretory COPII coat component SEC23B cause congenital dyserythropoietic anemia type II.

Authors:  Klaus Schwarz; Achille Iolascon; Fatima Verissimo; Nikolaus S Trede; Wyatt Horsley; Wen Chen; Barry H Paw; Karl-Peter Hopfner; Karlheinz Holzmann; Roberta Russo; Maria Rosaria Esposito; Daniela Spano; Luigia De Falco; Katja Heinrich; Brigitte Joggerst; Markus T Rojewski; Silverio Perrotta; Jonas Denecke; Ulrich Pannicke; Jean Delaunay; Rainer Pepperkok; Hermann Heimpel
Journal:  Nat Genet       Date:  2009-06-28       Impact factor: 38.330

3.  Congenital dyserythropoietic anemia type I (CDA I): molecular genetics, clinical appearance, and prognosis based on long-term observation.

Authors:  Hermann Heimpel; Klaus Schwarz; Monika Ebnöther; Jeroen S Goede; Detlev Heydrich; Torsten Kamp; Lothar Plaumann; Bettina Rath; Jochen Roessler; Otto Schildknecht; Mathias Schmid; Walter Wuillemin; Beate Einsiedler; Rosi Leichtle; Hannah Tamary; Elisabeth Kohne
Journal:  Blood       Date:  2005-09-01       Impact factor: 22.113

4.  Clinical and molecular variability in congenital dyserythropoietic anaemia type I.

Authors:  Hannah Tamary; Orly Dgany; Alexis Proust; Tatyana Krasnov; Nili Avidan; Tal Eidelitz-Markus; Gil Tchernia; David Geneviève; Valérie Cormier-Daire; Brigitte Bader-Meunier; Corinne Ferrero-Vacher; Martine Munzer; Ralph Gruppo; Eithan Fibach; Osnat Konen; Isaac Yaniv; Jean Delaunay
Journal:  Br J Haematol       Date:  2005-08       Impact factor: 6.998

Review 5.  Erythroid transcription factor EKLF/KLF1 mutation causing congenital dyserythropoietic anemia type IV in a patient of Taiwanese origin: review of all reported cases and development of a clinical diagnostic paradigm.

Authors:  Julie A Jaffray; W Beau Mitchell; Merlin Nithya Gnanapragasam; Surya V Seshan; Xinhuo Guo; Connie M Westhoff; James J Bieker; Deepa Manwani
Journal:  Blood Cells Mol Dis       Date:  2013-03-20       Impact factor: 3.039

6.  SEC23B is required for the maintenance of murine professional secretory tissues.

Authors:  Jiayi Tao; Min Zhu; He Wang; Solomon Afelik; Matthew P Vasievich; Xiao-Wei Chen; Guojing Zhu; Jan Jensen; David Ginsburg; Bin Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-28       Impact factor: 11.205

7.  Congenital dyserythropoietic anaemia with novel intra-erythroblastic and intra-erythrocytic inclusions.

Authors:  S N Wickramasinghe; N Illum; P D Wimberley
Journal:  Br J Haematol       Date:  1991-10       Impact factor: 6.998

8.  Codanin-1, the protein encoded by the gene mutated in congenital dyserythropoietic anemia type I (CDAN1), is cell cycle-regulated.

Authors:  Sharon Noy-Lotan; Orly Dgany; Roxane Lahmi; Nathaly Marcoux; Tanya Krasnov; Nissan Yissachar; Doron Ginsberg; Benny Motro; Peretz Resnitzky; Isaac Yaniv; Gary M Kupfer; Hannah Tamary
Journal:  Haematologica       Date:  2009-03-31       Impact factor: 9.941

9.  Linkage and mutational analysis of the CDAN1 gene reveals genetic heterogeneity in congenital dyserythropoietic anemia type I.

Authors:  Momin R Ahmed; Aref Chehal; Laila Zahed; Ali Taher; Joud Haidar; Ali Shamseddine; Anne-Marie O'Hea; Nicola Bienz; Orly Dgany; Nili Avidan; Jacqui S Beckmann; Hannah Tamary; Douglas Higgs; Paresh Vyas; William G Wood; Sunitha N Wickramasinghe
Journal:  Blood       Date:  2006-06-15       Impact factor: 22.113

10.  Homozygous mutations in a predicted endonuclease are a novel cause of congenital dyserythropoietic anemia type I.

Authors:  Christian Babbs; Nigel A Roberts; Luis Sanchez-Pulido; Simon J McGowan; Momin R Ahmed; Jill M Brown; Mohamed A Sabry; David R Bentley; Gil A McVean; Peter Donnelly; Opher Gileadi; Chris P Ponting; Douglas R Higgs; Veronica J Buckle
Journal:  Haematologica       Date:  2013-05-28       Impact factor: 9.941

View more
  46 in total

1.  KLF1-null neonates display hydrops fetalis and a deranged erythroid transcriptome.

Authors:  Graham W Magor; Michael R Tallack; Kevin R Gillinder; Charles C Bell; Naomi McCallum; Bronwyn Williams; Andrew C Perkins
Journal:  Blood       Date:  2015-02-27       Impact factor: 22.113

Review 2.  Erythro-megakaryocytic transcription factors associated with hereditary anemia.

Authors:  John D Crispino; Mitchell J Weiss
Journal:  Blood       Date:  2014-03-20       Impact factor: 22.113

Review 3.  Orchestration of late events in erythropoiesis by KLF1/EKLF.

Authors:  Merlin Nithya Gnanapragasam; James J Bieker
Journal:  Curr Opin Hematol       Date:  2017-05       Impact factor: 3.284

4.  [Hemoglobin disorders].

Authors:  R Dickerhoff
Journal:  Internist (Berl)       Date:  2015-09       Impact factor: 0.743

5.  Non-myeloablative allogeneic stem cell transplant with post-transplant cyclophosphamide cures the first adult patient with congenital dyserythropoietic anemia.

Authors:  A Oh; P R Patel; N Aardsma; S R Mehendale; R Chowdhery; K Sweiss; D Rondelli
Journal:  Bone Marrow Transplant       Date:  2017-03-20       Impact factor: 5.483

6.  Congenital Dyserythropoietic Anemia Type 1: Report of One Patient and Analysis of Previously Reported Patients Treated with Interferon Alpha.

Authors:  Ayse Salihoglu; Tugrul Elverdi; Ahmet Emre Eskazan; Deniz Eyice; Isil Bavunoglu; Muhlis Cem Ar; Seniz Ongoren; Elif Guzel; Zafer Baslar; Aydin Tunckale; Nukhet Tuzuner; Teoman Soysal
Journal:  Indian J Hematol Blood Transfus       Date:  2015-09-21       Impact factor: 0.900

7.  Hemolytic anemia with null PKLR mutations identified using whole exome sequencing and cured by hematopoietic stem cell transplantation combined with splenectomy.

Authors:  M Kim; J Park; J Lee; W Jang; H Chae; H Choi; J Kim; A Kwon; J-W Lee; B Cho; Y Kim; N-G Chung
Journal:  Bone Marrow Transplant       Date:  2016-09-05       Impact factor: 5.483

Review 8.  Nuances of Morphology in Myelodysplastic Diseases in the Age of Molecular Diagnostics.

Authors:  Aaron C Shaver; Adam C Seegmiller
Journal:  Curr Hematol Malig Rep       Date:  2017-10       Impact factor: 3.952

9.  Developmentally-faithful and effective human erythropoiesis in immunodeficient and Kit mutant mice.

Authors:  Claudia Fiorini; Nour J Abdulhay; Sean K McFarland; Mathias Munschauer; Jacob C Ulirsch; Roberto Chiarle; Vijay G Sankaran
Journal:  Am J Hematol       Date:  2017-07-19       Impact factor: 10.047

Review 10.  Society for Pediatric Research 2015 Young Investigator Award: genetics of human hematopoiesis-what patients can teach us about blood cell production.

Authors:  Aoi Wakabayashi; Vijay G Sankaran
Journal:  Pediatr Res       Date:  2015-11-17       Impact factor: 3.756

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.